Cognitive Behavioural Therapy as an Effective Treatment for Social Anxiety, Perfectionism, and Rumination

Sponsor
Alzahra University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03946735
Collaborator
(none)
52
2
12.6

Study Details

Study Description

Brief Summary

This randomized, controlled trial study was designed to examine the efficacy of Cognitive Behavioural Therapy (CBT) on social anxiety, perfectionism, and rumination among individuals diagnosed with social anxiety in Tehran, Iran.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioural Therapy as an Effective Treatment for Social Anxiety, Perfectionism, and Rumination
N/A

Detailed Description

A total of 52 individuals with Social Anxiety Disorder (SAD) (68% female, mean age = 35.67) were allocated to a CBT group or to a control group. The intervention group was given one session of therapy per week over a duration of 8 weeks, while the control group did not receive any intervention and was placed on a waiting list. Self-reported social anxiety, perfectionism, and rumination were measured before the CBT intervention, after the intervention, and two months after the intervention for both groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Cognitive Behavioural Therapy as an Effective Treatment for Social Anxiety, Perfectionism, and Rumination
Anticipated Study Start Date :
Dec 1, 2019
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Dec 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention study

Cognitive Behavioural Therapy for social anxiety

Behavioral: Cognitive Behavioural Therapy as an Effective Treatment for Social Anxiety, Perfectionism, and Rumination
Week one involved introducing CBT and assessing the negative effects of perfectionism, rumination, and social anxiety. Week two allowed participants to specify stressful social activities, stressful social situations, and enjoyable activities. Week three to week six allowed participants to identify automatic thoughts and thinking errors (for example, all or nothing thinking, self-criticism, dysfunctional schemas for self-evaluation, and unrealistic standards). Assignments were provided to participants with the content of exposure to anxiety evoking situations in the treatment sessions and at home. Achievable behavioural goals were set for participants in the treatment sessions and at home.

Experimental: Social anxiety

Behavioral: Cognitive Behavioural Therapy as an Effective Treatment for Social Anxiety, Perfectionism, and Rumination
Week one involved introducing CBT and assessing the negative effects of perfectionism, rumination, and social anxiety. Week two allowed participants to specify stressful social activities, stressful social situations, and enjoyable activities. Week three to week six allowed participants to identify automatic thoughts and thinking errors (for example, all or nothing thinking, self-criticism, dysfunctional schemas for self-evaluation, and unrealistic standards). Assignments were provided to participants with the content of exposure to anxiety evoking situations in the treatment sessions and at home. Achievable behavioural goals were set for participants in the treatment sessions and at home.

Outcome Measures

Primary Outcome Measures

  1. Change: Social anxiety [a measure assessing change between three time points (pre-test, post-test (after two months), and follow-up test (after four months)]

    Liebowitz Social Anxiety Scale for measuring social anxiety. this scale comprises of fear or anxiety and avoidance and sub-scales are combine (summed) to compute total score. Total score ranging from 0 to 144, and An individual who gets a total score over 60 in this measure is considered to have social anxiety

Secondary Outcome Measures

  1. Change: Rumination and Reflection [a measure assessing change between three time points (pre-test, post-test (after two months), and follow-up test (after four months))]

    Rumination and Reflection Questionnair for measuring rumination and reflection: This scale comprises rumination and reflection. Each sub-scale comprises 12 items, and total scores ranged from 12 to 60. An individual who gets higher score is considered to have high rumination/ reflection.

Other Outcome Measures

  1. Change:Perfectionism [a measure assessing change between three time points (pre-test, post-test (after two months), and follow-up test (after four months)]

    Almost Perfect Scale-Revised for measuring perfectionism: This scale comprises 23 items, but only 12 items associated to discrepancy (as a measure of maladaptive perfectionism or clinical perfectionism) are utilized in this study. Total scores ranged from 12 to 84 and higher score indicates higher level of perfectionism.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants formally diagnosed with SAD by psychologists who determined the individual meet criteria outlined by the Diagnostic and Statistics Manual for Mental Disorders (DSM-5)
Exclusion Criteria:
  • If participants report a history of psychiatric disorders within the past 12 months such as schizophrenia, dementia, depression, alcohol and other drug addiction.

  • Participants could not partake if they were pregnant

  • Participants enroll in another psychological treatment program.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Alzahra University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abbas Abdollahi, Principal investigator, Alzahra University
ClinicalTrials.gov Identifier:
NCT03946735
Other Study ID Numbers:
  • Alzahra123456789
First Posted:
May 13, 2019
Last Update Posted:
May 13, 2019
Last Verified:
May 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Abbas Abdollahi, Principal investigator, Alzahra University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 13, 2019